|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,118.00 GBX | +1.42% |
|
+7.19% | +9.63% |
| 14/02 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| 14/02 | Sector Update: Health Care Stocks Higher Friday Afternoon | MT |
Chart calendar AstraZeneca PLC
Upcoming events on AstraZeneca PLC
| 03/03/2026 | Daiwa Tokyo Investment Conference | Add to your calendar Google Apple ICS format |
| 04/03/2026 | UBS European Healthcare Conference | Add to your calendar Google Apple ICS format |
| 10/03/2026 | Bank of America Bus Tour | Add to your calendar Google Apple ICS format |
| 10/03/2026 | Leerink Global Healthcare Conference | Add to your calendar Google Apple ICS format |
| 11/03/2026 | Leerink Global Healthcare Conference | Add to your calendar Google Apple ICS format |
| 12/03/2026 | Kepler One Stop Shop Conference | Add to your calendar Google Apple ICS format |
| 24/03/2026 | BNP Paribas Exane Healthcare Conference | Add to your calendar Google Apple ICS format |
| 26/03/2026 | Goldman Sachs Biopharma Innovation Summit | Add to your calendar Google Apple ICS format |
| 29/04/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 23/07/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 05/11/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 11/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 23/04/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on AstraZeneca PLC
| 13/02/2026 | Roadshow - Day 2 |
| 13/02/2026 | Roadshow - Day 2 |
| 13/02/2026 | Roadshow - Day 3 |
| 13/02/2026 | Roadshow - Day 3 |
| 12/02/2026 | Roadshow - Day 1 |
| 12/02/2026 | Roadshow - Day 1 |
| 12/02/2026 | Roadshow - Day 2 |
| 12/02/2026 | Roadshow - Day 2 |
| 11/02/2026 | Roadshow - SEB |
| 11/02/2026 | Roadshow - Day 1 |
| 11/02/2026 | Roadshow - Day 1 |
| 11/02/2026 | Morgan Stanley Middle East Investment Forum |
| 10/02/2026 | Q4 2025 Earnings Call |
| 10/02/2026 | Q4 2025 Earnings Release |
| 13/01/2026 | J.P. Morgan Healthcare Conference |
| 07/01/2026 | SEB Nordic Seminar |
| 06/01/2026 | Bank of America EU Pharma R&D Call Conference |
| 16/12/2025 | Scotiabank Rare Disease Fireside Chat Conference |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No:258 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No:79 |
Past dividends on AstraZeneca PLC
| 07/08/2025 | Interim Payment 0.767 GBP |
| 20/02/2025 | Final Payment 1.68 GBP |
| 08/08/2024 | Interim Payment 0.776 GBP |
| 22/02/2024 | Final Payment 1.56 GBP |
| 10/08/2023 | Interim Payment 0.718 GBP |
| 23/02/2023 | Final Payment 1.628 GBP |
| 11/08/2022 | Interim Payment 0.764 GBP |
| 24/02/2022 | Final Payment 1.453 GBP |
| 12/08/2021 | Interim Payment 0.648 GBP |
| 25/02/2021 | Final Payment 1.374 GBP |
| 13/08/2020 | Interim Payment 0.696 GBP |
| 27/02/2020 | Final Payment 1.464 GBP |
| 08/08/2019 | Interim Payment 0.719 GBP |
| 28/02/2019 | Final Payment 1.468 GBP |
| 09/08/2018 | Interim Payment 0.684 GBP |
| 15/02/2018 | Final Payment 1.336 GBP |
| 10/08/2017 | Interim Payment 0.689 GBP |
| 16/02/2017 | Final Payment 1.502 GBP |
| 11/08/2016 | Interim Payment 0.687 GBP |
| 18/02/2016 | Final Payment 1.31 GBP |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 44 351 44 465 -0.26% | 45 811 45 716 0.21% | 54 073 53 340 1.37% | 58 739 58 651 0.15% | 62 405 | 66 320 |
|
EBITDA Million USD | Released Forecast Spread | 9 237 13 681 -32.49% | 13 580 15 477 -12.26% | 16 691 16 909 -1.29% | 19 476 19 668 -0.98% | 22 730 | 24 853 |
|
EBIT Million USD | Released Forecast Spread | 13 350 13 702 -2.57% | 14 534 15 036 -3.34% | 16 928 17 034 -0.63% | 18 478 18 819 -1.81% | 21 065 | 23 370 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 501 3 511 -28.78% | 6 899 9 269 -25.57% | 8 691 10 318 -15.77% | 12 402 12 888 -3.77% | 15 890 | 18 544 |
|
Net income Million USD | Released Forecast Spread | 3 288 4 262 -22.86% | 5 961 6 597 -9.64% | 7 035 8 172 -13.91% | 10 225 10 070 1.54% | 12 440 | 14 006 |
|
EPS USD | Released Forecast Spread | 2,11 2,81 -24.96% | 3,81 4,34 -12.22% | 4,50 5,33 -15.6% | 6,54 6,34 3.11% | 7,88 | 8,93 |
| Announcement Date | 09/02/23 | 08/02/24 | 06/02/25 | 10/02/26 |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12 679 11 812 7.34% | 12 938 12 528 3.28% | 25 617 12 560 103.96% | 13 565 13 102 3.53% | 14 891 14 181 5.01% | 13 588 13 741 -1.11% | 14 457 14 095 2.57% | 15 191 14 769 2.86% | 15 503 15 371 0.86% | 14 639 | 15 227 | 16 087 | 16 651 | 15 140 | 15 675 | 16 615 |
|
EBITDA Million USD | Released Forecast Spread | 4 025 4 305 -6.51% | 3 923 4 265 -8.01% | 4 373 5 435 -19.54% | 4 958 5 324 -6.87% | 4 897 4 284 14.31% | 5 132 4 936 3.97% | 4 489 6 081 -26.18% | 5 619 | 5 791 | 6 059 | 6 067 | |||||
|
EBIT Million USD | Released Forecast Spread | 4 310 3 911 10.2% | 4 101 4 016 2.11% | 8 411 4 052 107.58% | 4 318 4 177 3.37% | 4 199 4 300 -2.34% | 4 803 4 583 4.81% | 4 584 4 495 1.99% | 4 993 4 753 5.05% | 4 098 4 383 -6.51% | 5 157 | 5 020 | 5 433 | 5 277 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 800 2 296 21.95% | 2 397 2 395 0.08% | 1 828 2 873 -36.37% | 1 666 2 825 -41.03% | 3 127 2 874 8.8% | 3 244 3 487 -6.97% | ||||||||||
|
Net income Million USD | Released Forecast Spread | 2 179 2 065 5.52% | 1 927 2 130 -9.52% | 1 429 2 332 -38.72% | 1 500 3 284 -54.32% | 2 916 2 458 18.63% | 2 450 2 497 -1.87% | 2 533 2 782 -8.94% | 2 326 2 801 -16.95% | 3 241 | 3 119 | 3 485 | 3 151 | ||||
|
EPS USD | Released Forecast Spread | 1,41 1,33 6.28% | 1,24 1,36 -9% | 0,91 1,49 -39.13% | 0,96 2,11 -54.44% | 1,88 1,57 19.47% | 1,57 1,66 -5.38% | 1,62 1,78 -9.18% | 1,49 1,80 -17.29% | 2,08 | 2,00 | 2,24 | 2,02 | ||||
| Announcement Date | 25/04/24 | 25/07/24 | 25/07/24 | 12/11/24 | 06/02/25 | 29/04/25 | 29/07/25 | 06/11/25 | 10/02/26 | - | - | - | - | - | - | - |
| 18/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 23/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for AstraZeneca PLC
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2025 Earnings Release | |
| 13/02/2026 | Q3 2025 Earnings Release | |
| 13/02/2026 | Q4 2025 Earnings Release | |
| 13/02/2026 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZN Stock
- Calendar AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















